INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
04/12/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
SENTOSA
ST13
US500000079117643Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Drawing code
Owner type
Owner location
Examiner
Law office
Holders
Representatives
Stacy L. Emhoff Walker & Jocke Co., LPA
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules
Class 5
Pharmaceutical and veterinary preparations, namely, biological substances and chemicals used for medical scientific and medical research purposes, namely, reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes
Class 9
Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data
Class 10
Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes
Class 42
[ Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; [ development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data ] * all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis * ]
History of USPTO decisions and trademark events.
57 publications found
PARTIAL INVALIDATION PROCESSED BY THE IB
04/12/2025
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/13/2025
INVALIDATION PROCESSED
03/13/2025
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/30/2024
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
04/29/2024
REGISTERED - PARTIAL SEC 71 ACCEPTED
04/29/2024
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2024
TEAS SECTION 71 RECEIVED
08/28/2023
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/27/2022
INTERNATIONAL REGISTRATION RENEWED
06/17/2022
NEW REPRESENTATIVE AT IB RECEIVED
08/27/2021
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/16/2021
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/07/2019
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
05/07/2019
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/30/2019
TEAS SECTION 71 & 15 RECEIVED
04/08/2019
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/27/2018
PARTIAL INVALIDATION PROCESSED BY THE IB
02/20/2016
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2016
CHANGE OF OWNER RECEIVED FROM IB
02/12/2016
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/26/2016
INVALIDATION PROCESSED
01/26/2016
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/09/2015
NEW REPRESENTATIVE AT IB RECEIVED
04/10/2015
NEW REPRESENTATIVE AT IB RECEIVED
04/09/2015
LIMITATION FROM THE IB EXAMINED AND ENTERED
03/10/2015
CORRECTION UNDER SECTION 7 - PROCESSED
03/09/2015
ASSIGNED TO PARALEGAL
03/09/2015
LIMITATION OF GOODS RECEIVED FROM IB
03/05/2015
FINAL DECISION TRANSACTION PROCESSED BY IB
01/25/2014
FINAL DISPOSITION NOTICE SENT TO IB
12/06/2013
FINAL DISPOSITION PROCESSED
12/05/2013
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/27/2013
REGISTERED-PRINCIPAL REGISTER
08/27/2013
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2013
PUBLISHED FOR OPPOSITION
06/11/2013
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2013
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/06/2013
ASSIGNED TO LIE
05/03/2013
APPROVED FOR PUB - PRINCIPAL REGISTER
04/24/2013
TEAS/EMAIL CORRESPONDENCE ENTERED
04/03/2013
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2013
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2013
REFUSAL PROCESSED BY IB
10/26/2012
APPLICATION FILING RECEIPT MAILED
10/05/2012
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/04/2012
REFUSAL PROCESSED BY MPU
10/04/2012
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/04/2012
NON-FINAL ACTION WRITTEN
10/03/2012
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
10/03/2012
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/03/2012
NON-FINAL ACTION MAILED
10/02/2012
NON-FINAL ACTION WRITTEN
10/02/2012
ASSIGNED TO EXAMINER
10/01/2012
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2012
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/28/2012
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/28/2012
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.